| 1 |
34667110 | Anastrozole Regulates Fatty Acid Synthase in Breast Cancer. | 2022 Jan |
2 |
| 2 |
35128169 | A case report of cystoid macular edema, uveitis and vitreomacular traction in a patient taking Anastrozole. | 2022 Mar |
1 |
| 3 |
33608144 | Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903). | 2021 Apr |
2 |
| 4 |
33920789 | MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers. | 2021 Apr 15 |
2 |
| 5 |
34356536 | Role of Persistent Organic Pollutants in Breast Cancer Progression and Identification of Estrogen Receptor Alpha Inhibitors Using In-Silico Mining and Drug-Drug Interaction Network Approaches. | 2021 Jul 19 |
1 |
| 6 |
32098767 | Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α. | 2020 Jun 15 |
3 |
| 7 |
32701512 | Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action. | 2020 Aug 20 |
2 |
| 8 |
31002529 | Mammary adipose stromal cells derived from obese women reduce sensitivity to the aromatase inhibitor anastrazole in an organotypic breast model. | 2019 Jul |
1 |
| 9 |
31227223 | PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors. | 2019 Sep |
4 |
| 10 |
31328463 | PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progression. | 2019 Sep |
2 |
| 11 |
31479306 | Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update. | 2019 Nov 20 |
1 |
| 12 |
31523581 | Cancer Genes Mutations in Benign Metastasizing Leiomyoma: A Case Report. | 2019 Jul 16 |
2 |
| 13 |
29270913 | Fulvestrant: A Review in Advanced Breast Cancer Not Previously Treated with Endocrine Therapy. | 2018 Jan |
1 |
| 14 |
28643023 | Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients. | 2017 Oct |
2 |
| 15 |
27459535 | Endogenous Estrogen Regulates Somatostatin-Induced Rebound GH Secretion in Postmenopausal Women. | 2016 Nov |
1 |
| 16 |
28118723 | [Treatment with Aromatase Inhibitors in Postmenopausal Women with Breast Cancer and the Possibility of Influencing Side Effects]. | 2016 Fall |
1 |
| 17 |
25178514 | AR collaborates with ERα in aromatase inhibitor-resistant breast cancer. | 2014 Oct |
1 |
| 18 |
25203739 | The influence of genetic polymorphisms on the efficacy and side effects of anastrozole in postmenopausal breast cancer patients. | 2014 Dec |
1 |
| 19 |
22972694 | Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer. | 2013 Feb 15 |
1 |
| 20 |
23701964 | Anastrozole and RU486: Effects on estrogen receptor α and Mucin 1 expression and correlation in the MCF-7 breast cancer cell line. | 2013 Oct |
3 |
| 21 |
24047421 | Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer. | 2013 Sep 18 |
1 |
| 22 |
24076063 | Neoadjuvant treatment of endometrial cancer using anastrozole: a randomised pilot study. | 2013 Dec |
1 |
| 23 |
21777924 | Differentially expressed genes in window trials are influenced by the wound-healing process: lessons learned from a pilot study with anastrozole. | 2012 Jul |
2 |
| 24 |
22802308 | Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer. | 2012 Aug 20 |
1 |
| 25 |
20809360 | Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts. | 2011 Jul |
2 |
| 26 |
21916582 | Autophagy and endocrine resistance in breast cancer. | 2011 Aug |
1 |
| 27 |
20101208 | Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivity. | 2010 Apr 22 |
2 |
| 28 |
22993622 | Absence of the K303R estrogen receptor α mutation in breast cancer patients exhibiting different responses to aromatase inhibitor anastrozole neoadjuvant treatment. | 2010 Nov |
2 |
| 29 |
29147190 | Correlation Between Anthropometric Measures and Biomarker Changes After Neoadjuvant Therapy With Tamoxifen or Anastrozole in Postmenopausal Women With Breast Cancer. | 2010 Jun |
1 |
| 30 |
19250201 | Phase 3 trials of aromatase inhibitors for breast cancer prevention: following in the path of the selective estrogen receptor modulators. | 2009 Feb |
2 |
| 31 |
19515574 | Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy. | 2009 Oct |
1 |
| 32 |
18075758 | Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial. | 2008 Jun |
1 |
| 33 |
18451180 | Combination of anastrozole with fulvestrant in the intratumoral aromatase xenograft model. | 2008 May 1 |
1 |
| 34 |
16950593 | Metastatic breast cancer: an updating. | 2006 Nov |
1 |
| 35 |
16034487 | Anastrozole. | 2005 Apr |
2 |
| 36 |
16263272 | Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen. | 2005 Dec |
1 |
| 37 |
15368322 | Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer. | 2004 Sep 15 |
1 |
| 38 |
15719595 | Aromatase inhibitors in advanced breast cancer. | 2004 Dec |
1 |
| 39 |
12713499 | Treatment of breast cancer in countries with limited resources. | 2003 May-Jun |
1 |
| 40 |
14687437 | Focus on anastrozole and breast cancer. | 2003 |
1 |
| 41 |
12402060 | The evolving role of aromatase inhibitors in breast cancer. | 2002 Oct |
3 |